MedPath

Evaluating Early Initiation of Hybrid Closed Loop Therapy in Newly Diagnosed Type 1 Diabetes

Not Applicable
Recruiting
Conditions
Type 1 diabetes
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12624001050549
Lead Sponsor
Telethon Kids Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1. New Diagnosis of T1D between 31st May 2024 and 31st May 2025.
2. Age 1-17.99 years.
3. Willing to complete study questionnaires.

Exclusion Criteria

1. Age <1 year old (no TGA-approved HCL system for this age group).
2. Unwillingness to complete study questionnaires.
3. Does not have at least one caregiver that can read and write English for instruments that are not available in translated versions

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath